FLGT Q3 2025 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q3 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$84M+17.2% YoY

Gross Profit

$36M42.2% margin

Operating Income

-$15M-18.3% margin

Net Income

-$7M-7.9% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

+2.8%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$5M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$94M

Stockholders' Equity

$1.1B

Cash & Equivalents

$118M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$84M	$72M	+17.2%
Gross Profit	$36M	$27M	+32.7%
Operating Income	-$15M	-$17M	+10.1%
Net Income	-$7M	-$15M	+54.9%

Revenue Segments

Laboratory Services

$84M100%

Geographic Segments

UNITED STATES

$78M86%

Non-US

$6M7%

Other Countries

$3M4%

CHINA

$3M3%